stockrow
Friday 6 November 2026
Export OPTH’s income statement to Excel — free account
Optimi Health Corp.
OPTH Healthcare Drug Manufacturers Specialty & Generic
Optimi Health Corp.’s revenue for fiscal 2025 (year ended September 2025) was $304,800.00, up 6.39% from fiscal 2024.
2.29
0.08
+3.62%
Follow OPTH
Alert me
| Sep '25 | Sep '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(1.43) | 76.62 | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(9.95) | (6.50) | (6.43) | (6.43) |
P/Operating CF |
(886.50) | 0.00 | 0.00 | 0.00 |
P/B ratio |
142.93 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
142.93 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
0.15 | 0.07 | 0.07 | 0.07 |
Current Ratio |
0.22 | 0.38 | 0.38 | 0.38 |
Net Debt/EBITDA |
(0.67) | 0.02 | 0.02 | 0.02 |
Debt/Assets |
23.72% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.55 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.03 | 0.03 | 0.03 | 0.00 |
Operating CF/Net income |
0.71 | 0.71 | 0.00 | 0.00 |
Capex/Depreciation |
(0.09) | (0.18) | — | — |
Interest Coverage |
(8.67) | (11.78) | (11.45) | (11.45) |
| (45.23%) | 86.01% | 25.56% | 0.00% | |
| (24.61%) | (41.48%) | (41.48%) | 0.00% | |
ROIC |
(35.59%) | (36.21%) | (32.42%) | (32.42%) |
Return on Tangible Assets |
(64.86%) | (53.44%) | (53.44%) | (53.44%) |
Average Days of Receivables |
81.43 | 116.19 | 116.19 | 116.19 |
Research and Development Expense of Revenue |
81.56% | 37.07% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
274.97% | 498.50% | 1,107.26% | 1,107.26% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
10.89% | 15.43% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.10 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.59) | (0.04) | — | — |
Capex per Share |
(0.02) | 0.00 | — | — |
Free Cash Flow per Share |
(0.61) | (0.04) | — | — |
Cash per Share |
0.26 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
1.47 | 0.08 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | — | — |
Book value per Share |
1.47 | 0.08 | 0.00 | 0.00 |
Free Cash Flow |
(1.94) | (3.26) | — | — |
Working Capital |
(4.76) | (1.46) | (1.46) | (1.46) |
Capital Expenditures |
(0.06) | (0.11) | — | — |
Net Current Asset Value |
(4.87) | (2.75) | (2.75) | (2.75) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.21 | 0.39 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
0.08 | 0.07 | 0.00 | 0.00 |
Cash ROIC |
(23.99%) | (45.81%) | 0.00% | 0.00% |
Accounts Receivable Turnover |
3.83 | 3.14 | 3.14 | 0.00 |
Accounts Payable Turnover |
0.42 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.80 | 0.13 | 0.13 | 0.00 |
Average Days of Payables |
1,026.75 | 2,831.05 | 0.00 | 0.00 |
Days of Inventory on Hand |
229.12 | 2,746.27 | 2,746.27 | 2,746.27 |
Average Receivables |
0.08 | 0.09 | 0.09 | — |
Average Payables |
0.84 | — | — | — |
Average Inventory |
0.44 | 0.66 | 0.66 | — |
Average Assets |
10.78 | 10.69 | 10.69 | — |
Average Common Equity |
5.87 | (5.16) | (17.35) | — |
Columns are period end dates · fundamentals updated 2 Nov 2026